Landmark Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer

Source :: PR Newswire. October 17, 2024
Publication Year :: 2024
Abstract: Positive study enables valuable repositioning of new antifibrotic drug candidates by a growing number of pharma companies SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- MeCo Diagnostics, a venture-backed startup dedicated [...]

Subjects :: Oncology, Experimental -- Health aspects
Chemotherapy -- Health aspects -- Research
Drug approval -- Health aspects -- Research
Cancer -- Chemotherapy -- Research
Breast cancer -- Care and treatment -- Research
Business
News, opinion and commentary

Tools